Newsroom
Our newsroom provides you with the latest corporate news and ad hoc press releases.
We aim to foster a transparent, continuous and trusting dialogue with all capital market participants. Please reach out in case of questions or if you would like to provide feedback.
The annual online report provides insights into an eventful 2023, with the Chairman of the Board of Directors and CEO reporting on the latest developments regarding the e-prescription.
Our newsroom provides you with the latest corporate news and ad hoc press releases.
Get the latest information on market trends, financials and the strategy of DocMorris.
DocMorris grows in the prescription business and invests incrementally in new Rx customers.
Discover the presentation of our most recent Capital Markets Day.
In 2023, DocMorris cut CO2 emissions by 13%, reduced its already low gender pay gap, raised awareness of cybersecurity among employees and implemented a Supplier Code of Conduct.
DocMorris is ideally positioned to deliver on the eRx (e-prescription) opportunity in Germany and execute its strategy to build the digital healthcare ecosystem of choice.
Want to know more? Our Investor Relations team will be glad to answer any questions you may have about the DocMorris share and related capital market topics.
Additional contacts can be found here:
